These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4990207)

  • 1. [Therapy of blood protein disorders].
    Wuhrmann F
    Clin Ter; 1970 May; 53(4):291-8. PubMed ID: 4990207
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood volume and hematocrit value in macroglobulinemia and myeloma.
    Kopp WL; MacKinney AA; Wasson G
    Arch Intern Med; 1969 Apr; 123(4):394-6. PubMed ID: 4976452
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dysgammaglobulinemia].
    Sari F
    Soins; 1980 Aug; 25(15-16):31-8. PubMed ID: 6773149
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in treatment of multiple myeloma and Waldenström's macroglobulinemia.
    Alexanian R; Weber D
    Biomed Pharmacother; 2001 Nov; 55(9-10):550-2. PubMed ID: 11769965
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of serum viscosity measurements in assessing the response to therapy in myeloma and Waldenström's macroglobulinaemia.
    Kok DA
    Bibl Anat; 1967; 9():252-8. PubMed ID: 4961775
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hemoblastoses. V. Plasmocytoma and macroglobulinemic reticulosis of Walderström].
    Danieli G
    G Clin Med; 1967 Feb; 48(2):164-74. PubMed ID: 4971622
    [No Abstract]   [Full Text] [Related]  

  • 7. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J; Montoto S; Rosiñol L; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of Waldenström disease].
    Wuhrmann F; Märki HH
    Dtsch Med Wochenschr; 1968 Apr; 93(16):822-3. PubMed ID: 4171110
    [No Abstract]   [Full Text] [Related]  

  • 9. Brief review: diagnosing and managing plasma cell (multiple) myeloma.
    Mass RE
    Geriatrics; 1978 Jul; 33(7):53-5, 60-1. PubMed ID: 97174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of combination chemotherapy for multiple myeloma and macroglobulinemia--VENAP therapy (author's transl)].
    Furukawa K; Fujiwara Y; Nakaide Y; Tanaka M; Tanaka M; Hirota Y
    Rinsho Ketsueki; 1980 Nov; 21(11):1683-91. PubMed ID: 6782278
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytostatic therapy of hemoblastosis].
    Ehrhart H
    Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
    [No Abstract]   [Full Text] [Related]  

  • 12. [The plasmatic hyperviscosity syndrome].
    Azzena D; Astengo F; Lercari G; Azzolini A
    Clin Ter; 1968 Jul; 46(2):131-8. PubMed ID: 4973952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current treatment of Kahler's disease and Waldenström's macroglobulinemia].
    Seligmann M; Meshaka G
    Sem Ther; 1965; 41(6):373-5. PubMed ID: 4964847
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple myeloma. Clinical practice guidelines in oncology.
    Anderson KC; Alsina M; Bensinger W; Biermann JS; Chanan-Khan A; Comenzo RL; De Castro CM; Djulbegovic B; Farag S; Huff CA; Meredith R; Schriber J; Shrieve D; Singhal S; Smith MR; Stockerl-Goldstein K; Vose JM; Weber D; Yahalom J; Yunus F;
    J Natl Compr Canc Netw; 2007 Feb; 5(2):118-47. PubMed ID: 17335683
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple myeloma and other plasma cell dyscrasias].
    del Potro Gómez E; Morales Sanz D
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():52-7. PubMed ID: 10422451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current therapy of malignant blood diseases].
    de Werra P
    Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of multiple myeloma (generalized plasmacytoma)].
    Andreeva NE; Antipova LG
    Probl Gematol Pereliv Krovi; 1975 Mar; 20(3):51-7. PubMed ID: 768974
    [No Abstract]   [Full Text] [Related]  

  • 18. [Principles of treatment of hemoblastoses under ambulatory conditions].
    Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
    Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
    [No Abstract]   [Full Text] [Related]  

  • 19. Second malignancies and chemotherapeutic agents.
    Kyle RA
    Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes.
    Sakalová A; Gazová S; Hrubisko M; Gáliková J
    Neoplasma; 1973; 20(3):335-9. PubMed ID: 4199115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.